Clinical trial

Safety and Tolerability of ISX (Isoxsuprine HCL) in MS Relapses

NCT03752307

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Isoxsuprine Hydrochloride Normalized identity: isoxsuprine hydrochlorideView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Corticosteroid Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Safety and Tolerability of ISX (Isoxsuprine HCL) in MS Relapses

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1, PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-02-15

PhasePHASE1 / PHASE2

Conditions

Multiple Sclerosisverified · MONDO: multiple sclerosis

Interventions

Isoxsuprine HydrochlorideDRUG · verified · RxNorm: isoxsuprine hydrochloride

PlaceboDRUG

CorticosteroidDRUG

Sponsors & collaborators

University of New Mexicolead sponsor

Mapped research locations

AlbuquerqueNew Mexico, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03752307 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.